Transperineal (TP) biopsies are emerging as the biggest trend in the care of men on AS for prostate cancer since the mpMRI and genomic testing. The European Urological Association in January 2021 recommended TP as the first choice for biopsies. The American Urological Association will be debating this technology change at its annual meeting in the fall.
A.S.P.I. has assembled an expert panel to discuss why this change is being made, the potential to eliminate sepsis, impact on stewardship of antibiotics, and the differences between transrectal and transperineal biopsies. The discussion will be followed by a question-and-answer period.
Transperineal biopsies : What are they? Part 1 – Speakers
Share this: